BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

First published online January 19, 2009
British Journal of Radiology (2009) 82, 571-576
© 2009 British Institute of Radiology
doi: 10.1259/bjr/38306763

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by NARICULAM, J
Right arrow Articles by SWINN, M J
PubMed
Right arrow PubMed Citation
Right arrow Articles by NARICULAM, J
Right arrow Articles by SWINN, M J
British Journal of Radiology 82 (2009),571-576 ©2009 The British Institute of Radiology

Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer

J NARICULAM, MBBS, MRCS 1 D G MURPHY, MBBS, MD, FRCS 2 C JENNER, RGN 3 N SELLARS, MBBS, MRCP, FRCR 3 S GWYTHER, MBBS, FRCS, FRCR 3 S G GORDON, FRCS 4 and M J SWINN, BSc, MBBS, FRCS, MSc, MD, FRCS (UROL) 3

1 St Helier Hospital, Carshalton, Surrey, 2 Guy's Hospital, London, 3 East Surrey Hospital, Redhill, 4 Epsom and St Helier NHS Trust, Epsom, Surrey, UK

Correspondence: Joseph Nariculam, Flat 3, Lodden Lodge, 10 Devonshire Avenue, Sutton SM2 5JL, UK. E-mail: jnariculam{at}yahoo.co.uk

Ureteric obstruction causing renal failure is a serious complication of advanced prostate cancer. Percutaneous nephrostomies (PCNs) are used to decompress the obstructed kidney(s). This study aims to identify whether bilateral PCN insertion confers any advantage over unilateral PCN insertion for patients with bilateral ureteric obstruction. In a cohort of 25 patients, 18 underwent bilateral and 7 underwent unilateral PCN insertion. The mean survival time following PCN was 7.5 months for all patients. The data suggest that the nadir serum creatinine after PCN insertion was similar, independent of whether one or two nephrostomies were inserted. There was also little difference in the serum creatinine levels at the time of death, suggesting that survival after PCN insertion is based on the aggressiveness of the prostate cancer as opposed to the number of nephrostomies inserted.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2009 by the British Institute of Radiology.